We noticed you’re blocking ads

Thanks for visiting CRSTG | Europe Edition. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstodayeurope.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Up Front | Mar 2006

A Symptomatic Post-LASIK Eye

A 33-year-old white female underwent bilateral LASIK in 2002. Her preoperative refractions were -6.00 D OD and -6.50 -0.25 X 40º OS for a BCVA of 20/20 in both eyes. Ever since surgery, both of her eyes have had a poor quality of vision, despite a UCVA of 20/25. Her right eye is much more symptomatic than her left. Ultrasound pachymetry currently measures 490 µm OD and 480 µm OS. The treatment was well centered and the optical zone is normal in the patient's right eye (Figure 1). Her pupils are normal and within the optical zone diameter for scotopic and photopic conditions.

The patient has a manifest refraction of +0.25 -0.75 X 163º = 20/20-1 OD and +0.25 -0.75 X 80º = 20/20-1 OS. Her cycloplegic refraction measures +0.75 -0.50 X 107º = 20/20-1 OD and +1.75 -0.75 X 075º = 20/20-1 OS. Figures 2 and 3 show the results of wavefront analysis in both of the patient's eyes. Without cycloplegia, her wavefront refraction is -1.31 -0.70 X 153º OD, with a root mean square (RMS) (higher-order aberrations) value of 0.73. The measurement in her left eye was -0.28 -0.55 X 79º, with an RMS (higher-order aberrations) value of 0.73. With cycloplegia, her wavefront refraction is +0.89 -0.66 X 104º OD, with an RMS (higher-order aberrations) value of 0.81. The measurement in her left eye is +1.87 -0.81 X 74, with an RMS (higher-order aberrations) value of 0.65.

The patient's operative report reveals that she has adequate residual stroma for an enhancement. She prefers to undergo a retreatment in her right eye only at this time. How would you proceed?

PAUL HUGHES, MD
Bilateral LASIK for myopic astigmatism overcorrected both of the patient's eyes, but her left to a greater degree. I find her manifest refraction hard to believe and think her undilated wavefront refraction more credible. I think this patient's problem relates to three areas: accommodation, residual refractive error and a decreased quality of vision due to higher-order aberrations.

I believe that she is using accommodation to correct the hypermetropic astigmatism in her left eye and is thus inducing myopia in her right eye. As a result, her right eye is more symptomatic. If one treats her right eye and corrects the cycloplegic hypermetropic astigmatism, she will be worse off when she accommodates to correct her left eye.

I would recommend a contact lens trial to demonstrate to the patient that her main problem is an overcorrected left eye (ie, a +1.00-D soft contact lens on her left eye will improve the poor vision in her right eye). Hard contact lenses would be a better option than soft spherical lenses, because the former would also correct her astigmatism.

The patient should be informed that she requires a correction of both eyes. If she agreed to bilateral enhancements, I would treat her left eye first with slightly less than her dilated wavefront refraction (ie, +0.75 +0.81 X 164º). I would then treat her right eye, again with slightly less than her dilated wavefront refraction (ie, plano +0.66 X 104º).

The trap in this case is not recognizing the role of accommodation and allowing for it when performing the enhancement. I would complete a wavefront-optimized treatment using the Allegretto excimer laser (Wavelight Laser Technologie AG, Erlangen, Germany).

MIRKO JANKOV, MD
First, I would perform a second evaluation with a topographer I have found to be reliable, such as the Allegro Topolyzer (Wavelight) or the Oculus Pentacam (Oculus Optikgeräte GmbH, Wetzlar, Germany). I doubt that the optical zone is indeed sufficiently large, considering the amount of myopia
(-6.00 D) that was originally treated. The Orbscan's elevation map with floating best-fit sphere (Figure 1) shows a typical pattern of a small optical zone: a doughnut-shaped elevation around a small, more depressed, central area. A change in the power of wavefront sphere from 4 mm to 6 mm by more than 2.00 D (Figure 2 and 3), while the difference between manifest and cycloplegic sphere is only 0.50 D as expected, clearly demonstrates that a large amount of spherical aberration is present in this eye — a hallmark of a small optical zone.

If the spherical aberration were the only aberration (in significant amounts) in this eye, I would simply perform a topography-guided treatment in order to enlarge the optical zone. Two important details, however, draw my attention: The eye's astigmatism changes its power and axis when the pupil is dilated, and significant coma is present even with a small pupil. I would therefore verify that the crystalline lens is not causing this patient's astigmatism. How much cylinder is induced because the shape of the crystalline lens changes as the pupil dilates? How much of her poor visual quality is due to a combination of other higher-order aberrations that have been misinterpreted as astigmatism?

I would also repeat the wavefront measurements with a large pupil but perform dilation with a weak mydriatic agent (eg, phenylephrine 5% or 10%, two drops every 5 minutes, measurement taken 30 minutes after instillation). This analysis would be the manifest wavefront refraction; it would be free of an astigmatic shift due to a change in lenticular shape. In the spherical part of the planned correction, I could easily take into account the expected amount of accommodation.The presence of significant coma (both third and fifth order, although the former to a greater degree), higher-order astigmatism and spherical aberration leads me to believe that a wavefront-guided treatment would be the best option.

MATTHIAS J. MAUS, MD
The patient complains about a diminished quality of vision without specifying the circumstances. The fact that the patient does not wear spectacles despite her residual refractive error may be the first reason for her poor perceived quality of vision. Residual astigmatism is well known to enable patients to see without glasses, while reducing the overall quality of the retinal image, especially at night.

A LASIK enhancement targeting physiological asphericity is an option, but which refraction is the right one? The difference in sphere, cylinder and axis between the manifest and cycloplegic refractions necessitates further evaluation. The topography appears normal for a post-LASIK eye, but it shows different axes compared with the two refractions. There is no evidence that her poor quality of vision is due to a specific disorder in the shape of her cornea. I would therefore recommend against a topography-guided retreatment.

The wavefront-based refraction in the dilated and undilated eye shows greater variance (up to 2.25 D) than the phoropter-based measurements. The reason must relate to higher-order aberrations. Coma and trefoil remain about the same regardless of dilation, and most other higher-order aberrations are of minor importance. Spherical aberration (C12), however, is three times greater in this eye with a dilated versus an undilated pupil. This difference definitely accounts for the change in the eye's refraction. The overall higher-order RMS of approximately 0.80 is known to cause poor visual quality, especially in low-lighting conditions when the pupil enlarges. I recommend a wavefront-guided retreatment using the wavefront measurement that was acquired with dilated pupils. This refraction accords with the cycloplegic refraction.

Section editor A. John Kanellopoulos, MD, is a corneal and refractive surgery specialist. Dr. Kanellopoulos is director of Laservision Eye Institute in Athens, Greece, and practices New York. He is attending surgeon for the department of ophthalmology at the Manhattan Eye, Ear, and Throat Hospital in New York and clinical associate professor of ophthalmology at New York University Medical School. He has no financial interest in any product or company mentioned. Dr. Kanellopoulos is a member of the CRSToday Europe Editorial Board and may be reached at laservision@internet.gr or +30 21 07 47 27 77.

Paul Hughes, MD, is senior medical consultant at Southline Eye Centre in Hurtsville, New South Wales, Australia. He states that he holds no financial interest in the products or companies mentioned. Dr. Hughes may be reached at paulhughes@southline.com.au.

Mirko Jankov, MD, is a senior medical consultant at Milos Clinic Eye Hospital Medical Academy – US Medical School, in Belgrade, Serbia and Montenegro. He is a clinical consultant for Wavelight Laser Technologie AG. Dr. Jankov may be reached at visioncare@mac.com or +381 11 245 5759.

Matthias J. Maus, MD, is medical director of refractive surgery at Augenzentrum Maus+Heiser in Cologne, Germany. He is a clinical consultant to Wavelight Laser Technologie AG. Dr. Maus is a member of the CRSToday Europe Editorial Board. He may be reached at maus@augenzentrum.de or +49 221 8601613.

NEXT IN THIS ISSUE